HELICOS BIOSCIENCES CORP 4
4 · HELICOS BIOSCIENCES CORP · Filed May 31, 2007
Insider Transaction Report
Form 4
AGTC ADVISORS FUND LP
10% Owner
Transactions
- Conversion
Common Stock
2007-05-30+2,986,674→ 3,106,797 total(indirect: See footnote.) - Purchase
Common Stock
2007-05-30$9.00/sh+222,222$1,999,998→ 3,329,019 total(indirect: See footnote.) - Conversion
Series A Redeemable Convertible Preferred Stock
2007-05-30−6,727,857→ 0 total(indirect: See footnote)→ Common Stock (1,495,076 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2007-05-30−6,712,209→ 0 total(indirect: See footnote.)→ Common Stock (1,491,598 underlying)
Footnotes (6)
- [F1]The preferred stock automatically converted upon the closing of the issuer's initial public offering, on a 4.5-for-one basis.
- [F2]Consists of 106,337 shares held by AGTC Advisors Fund, L.P. ("AGTC"), 1,759,235 shares held by Applied Genomic Technology Capital Fund, L.P. ("AGTC Fund" and together with AGTC, the "AGTC Funds"), 702,734 shares held by Flagship Ventures Fund 2004, L.P. ("Flagship"), 39,848 shares held by NewcoGen Elan LLC ("NewcoGen Elan"), 203,461 shares held by NewcoGen Equity Investors LLC ("NewcoGen Equity"), 236,283 shares held by NewcoGen Group, LLC ("NewcoGen Group"), 42,385 shares held by NewcoGen PE LLC ("NewcoGen PE"), 8,280 shares held by NewcoGen Long Reign Holding LLC ("NewcoGen Long Reign") and 8,234 shares of ST NewcoGen LLC ("ST NewcoGen" together with NewcoGen Elan, NewcoGen Equity, NewcoGen Group, NewcoGen PE and NewcoGen Long Reign, the "NewcoGen Funds").
- [F3]NewcoGen Group, Inc. ("NewcoGen Inc.") is the manager of each of the NewcoGen Funds and the general partner of AGTC Partners, L.P. which is the general partner of each of AGTC Funds. NewcoGen Inc. is a wholly owned subsidiary Flagship Ventures Management, Inc. ("Flagship Inc.") Flagship Ventures General Partner LLC ("Flagship LLC") is the general partner of Flagship Ventures Fund 2004, L.P. Noubar B. Afeyan PhD and Edwin M. Kania, Jr. are the directors of Flagship Inc. and managers of Flagship LLC and may be deemed to share voting and investment power with respect to all shares held by the NewcoGen Funds, Flagship and the AGTC Funds. Each of Dr. Afeyan and Mr. Kania disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F4]Consists of 298,268 shares held by AGTC, 4,934,510 shares held byAGTC Fund, 128,215 shares held by NewcoGen Elan, 654,631 shares held by NewcoGen Equity, 522,720 shares held by NewcoGen Group, 136,373 shares held by NewcoGen PE, 26,643 shares held by NewcoGen Long Reign and 26,497 shares of ST NewcoGen.
- [F5]Consists of 180,252 shares held by AGTC, 2,982,055 shares held by AGTC Fund, 3,162,306 shares held by Flagship, 51,108 shares held by NewcoGen Elan, 260,946 shares held by NewcoGen Equity, 54,360 shares held by NewcoGen PE, 10,620 shares held by NewcoGen Long Reign and 10,562 shares of ST NewcoGen.
- [F6]Consists of 111,893 shares held by AGTC, 1,864,790 shares held by AGTC Fund, 813,845 shares held by Flagship, 39,848 shares held by NewcoGen Elan, 203,461 shares held by NewcoGen Equity, 236,283 shares held by NewcoGen Group, 42,385 shares held by NewcoGen PE, 8,280 shares held by NewcoGen Long Reign, and 8,234 shares of ST NewcoGen.